MAMMÔ 2026 Day 1 Highlights: From Early Detection and Precision Diagnostics to Treatment De-escalation and Global Breast Cancer Care
FDA Approved Atezolizumab Plus Chemotherapy for Stage III dMMR Colon Cancer
Who Shaped Oncology in the First Half of 2026: Breaking Down Approvals by Indications
Enrique Grande: Exploring Long-Term Outcomes and Predictive Biomarkers of Pembrolizumab in Advanced Renal Cell Carcinoma
Emanuela Palmerini: Connecting, Learning and Advancing Oncology at OncoDaily Grand Rounds in Madrid
Bogda Koczwara Named Candidate for UICC Board of Directors 2026–2028
Armenia Grants World's First Marketing Authorizations for BOT+BAL in MSS mCRC
The Cancer Elimination Collaboration Welcomed Ophira Ginsburg and Dorothy Keefe to the University of Sydney
